bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly
bamlanivimab/etesevimab (LY-CoV555/LY-CoV016) - Eli Lilly
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
etesevimab (JS016) - Chinese Academy of Sciences, Shanghai Junshi Biosci, Eli Lilly
http://clinicaltrials.gov/ct2/show/NCT04427501
 
May 12, 2023
 
Prev Next